Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,466
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
Nazarius Tumwesigye Mbona
ID: UNCST-2019-R000664
 A Midline Evaluation for a 5 Year Family Planning Implementation Program: The RISE Project in Uganda
REFNo: HS1296ES

1. Describe the socio-demographic characteristics of men and women of reproductive age living in the seven RISE regions at midway of implementation of RISE programme
2. Assess the program progress from baseline to midline on each of the following program intervention areas
a. men and women’s knowledge of FP services and methods in the project areas
b. men and women’s attitudes towards FP in the project areas
c. FP practices amongst men and women of reproductive age in the project areas
d. the intention to use FP services in future among men and women of reproductive age in the project areas
e. Ability and willingness to pay for FP services among men and women of reproductive age group in the project areas
f. level of exposure to SBCC messages on FP amongst men and women of reproductive age in the project areas
g. status of FP user segments for both men and women of reproductive age in the project areas in terms of Knowledge, attitude, practices, intent to use, exposure
3. Assess the effect of COVID-19 on access of family planning services among men and women of reproductive age living in the seven RISE regions at midway of implementation of RISE programme

 Uganda 2021-03-31 2024-03-31 Medical and Health Sciences Non-degree Award
Moses Ocan
ID:
Predictors of local emergence and spread of Artemisinin resistance among Ugandan Plasmodium falciparum parasites
REFNo: HS1169ES

(i) To assess the extent of adherence to national malaria treatment guidelines/policy in malaria treatment in private hospitals, private pharmacies and public hospitals in low and high malaria transmission settings in Uganda
(ii) To determine the prevalence of Pfkelch13 gene mutations among P. falciparum parasites in low and high malaria transmission settings in Uganda
(iii) To determine the prevalence of fd (ferredoxin), arps10 (apicomplast ribosomal protein S10) , mdr-2 (multi-drug resistance protein -2) and crt (chloroquine resistance protein) mutations among Plasmodium falciparum parasites in low and high malaria transmission settings in Uganda

 Uganda 2021-03-26 2024-03-26 Medical and Health Sciences Non-degree Award
Pakoyo Kamba Fadhiru
ID:
Scaling up the Refugees and Host Community’s response towards COVID-19 in Northern Uganda
REFNo: SS755ES

1. To assess the refugee and host communities’ compliance with COVID-19 infection prevention and control measures such as social distancing, hand washing, hand sanitization, use of personal protective equipment, quarantine and notification of cross-border travellers and suspect cases to authorities. 2. To identify community-led initiatives towards COVID-19 infection prevention and control. 3. To build the capacity of refugee settlement and community leaders in COVID-19 infection prevention and control.
Uganda 2021-03-26 2024-03-26 Social Science and Humanities Non-degree Award
Shevin  Jacob Thomas
ID:
EVALUATION OF PHARMACOKINETICS, SAFETY AND FEASIBILITY FOR ADMINISTRATION OF TWO DOSES OF INTRAVENOUS VITAMIN C COMBINED WITH VITAMIN B1 FOR THE MANAGEMENT OF ADULT PATIENTS ADMITTED WITH SEPSIS TO KIRUDDU NATIONAL REFERRAL HOSPITAL Short Title: RANDOMISED EVALUATION OF A VITAMIN C BUNDLE FOR SEPSIS TREATMENT IN AFRICA (REVISTA-DOSE)
REFNo: HS1236ES

General objective: In the future REVISTA-RCT, we intend to evaluate the components of a metabolic bundle comprising vitamin C, vitamin B1, and corticosteroids in order to determine if a combined effect of the bundle has greater efficacy (than bundle components or placebo) in decreasing 28-day mortality due to sepsis in adult patients in SSA. In preparation for the RCT, we intend to utilize the REVISTA-DOSE study to answer key questions about optimal dosing and safety for intravenous vitamin C (in combination with vitamin B1) in patients hospitalized with adult sepsis in two Ugandan referral hospitals. Primary objectives: 1. Describe the dose-plasma concentration response from two different doses of intravenous vitamin C (in combination with vitamin B1) Secondary objectives: 1. Evaluate the safety and tolerability of intravenous vitamin C (in combination with vitamin B1) in adult medical patients with sepsis in Uganda 2. Assess the enrolment rates, adherence to protocol and feasibility of conducting an RCT in patients with sepsis within the ARCS cohort of patients Exploratory objectives: 1. Evaluate association of vitamin C and vitamin B1 levels on clinical parameters/markers, including those for: a. Disease severity: shock; lactate clearance; qSOFA score; ability to stand unaided b. Inflammation, infection: Procalcitonin c. Organ/metabolic function, including: renal function d. Adverse events: hemolysis; oxaluria e. Outcomes: re-hospitalization frequency; length of hospitalization; 6 or 7 and 28d morbidity and mortality
USA 2021-03-26 2024-03-26 Medical and Health Sciences Non-degree Award
Barbara Mukasa
ID:
Evaluating the Glycemic Effects of Dolutegravir (DTG) Among Patients Receiving Dolutegravir Based Regimens at Mildmay Uganda ART sites : A Prospective Cohort Study
REFNo: HS1273ES

1.To determine the incidence of hyperglycaemia among patients receiving DTG based regimen at Mildmay Uganda supported sites. 2.To determine the association between previous NRTI or NRTtI exposure and the incidence of hyperglycemia among patients on TLD.
3.Evaluate predictors of hyperglycaemia among patients on TLD. 4.Describe other adverse events reported by study participants during the study period.
Uganda 2021-03-26 2024-03-26 Medical and Health Sciences Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS